
Throughout February, March and April, donations made to Parasites Without Borders (PWB) will be matched by the organization and donated to the American Society of Tropical Medicine and Hygiene (ASTMH)
March 23, 2023
Prior COVID-19 infection associated with increased risk of newly diagnosed erectile dysfunction | A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 story | Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households | Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system |
Projected COVID-19 Mortality Reduction From Paxlovid Rollout |
SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity | Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis | Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
March 16, 2023
Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea | Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19 | Clearance of longstanding, immune-deficiency-associated, vaccine-derived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection | Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months |
Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19 |
Optimal Duration of Systemic Corticosteroids in COVID-19 Treatment | SARS-CoV-2 Exposure in Norway Rats (Rattus norvegicus) from New York City | Exhaled Breath Aerosol Shedding of Highly Transmissible Versus Prior Severe Acute Respiratory Syndrome Coronavirus 2 Variants
March 09, 2023
Community-onset bacterial coinfection in children critically ill with SARS-CoV-2 infection |
Risk of Coronavirus Disease 2019–Associated Pulmonary Aspergillosis Based on Corticosteroid Duration |
Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection | Long-term gastrointestinal outcomes of COVID-19 | Confronting the evolution and expansion of anti-vaccine activism in the USA |
Effectiveness of Maternal Influenza Vaccination in Peru PRIME Cohort |
Bivalent booster effectiveness against severe COVID-19 outcomes in Finland | Immunomodulators for severe coronavirus disease-2019 in transplant patients | Characteristics and predictors of persistent symptoms post-COVID-19 in children and young people | Parental Nonadherence to Health Policy Recommendations for Prevention of COVID-19 | Viral kinetics of sequential SARS-CoV-2 infections |
Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population | One-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition
March 2, 2023
Fatal Fulminant Cerebral Edema in Six Children With SARS-CoV-2 Omicron BA.2 Infection in Taiwan |
Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children |
COVID-19 vaccines versus pediatric hospitalization | Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 | Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children |
Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid | Effect of covid-19 vaccination on long covid: systematic review |
FDA Authorizes First Over-the-Counter At-Home Test to Detect Both Influenza and COVID-19 Viruses |
Epidemiologic Characteristics of SARS-CoV-2 Recombinant Variant XBB.1.5 | Certifying Deaths Due to Coronavirus Disease 2019
February 23, 2023
Sex differences in cardiovascular complications and mortality in hospital patients with covid-19 |
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults | A third vaccine dose equalizes the levels of effectiveness | Sotrovimab retains activity against SARS-CoV-2 Omicron variant | Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients | Viral burden rebound in hospitalized patients with COVID-19 receiving oral antivirals | Serological response to vaccination in post-acute sequelae of COVID | Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 Infection | Past SARS-CoV-2 infection protection against re-infection | Postacute Sequelae of SARS-CoV-2 in University Setting
February 16, 2023
Intra-Host Evolution Provides for the Continuous Emergence of SARS-CoV-2 Variants | A Randomized Trial Comparing Omicron-Containing Boosters with the Original Covid-19 Vaccine mRNA-1273 | The political polarization of COVID-19 treatments among physicians and laypeople in the United States | Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study | SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster | The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England
- 1
- 2
- 3
- …
- 26
- Siguiente »
Situation Dashboards

World Health Organization (WHO)
Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)

Johns Hopkins University (JHU)
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU

COVID-19 in US and Canada
1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources

Genomic Epidemiology COVID-19
Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.